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Abstract: 
Background: Infections by parasites, bacteria, viruses such as human parvovirus B19 amongst 
others, have been widely reported as contributing to high prevalence of anaemia in many populations. 
This study was conducted to determine the co-infection of Plasmodium falciparum and human 
parvovirus B19 among sickle cell disease (SCD) patients in Benin City, Edo State, Nigeria. 
Methodology: A total of 400 participants consisting 300 SCD patients (134 males, 166 females) and 
100 (38 males, 62 females) apparently healthy subjects with haemoglobin AA (which served as 
control) who were contacted in homes, schools and offices, were enrolled for the study. The age of the 
participants ranged from 1 to 54 years. Venous blood was collected for detection of P. falciparum 
using Giemsa stain while parvovirus B19 was detected with enzyme linked immunosorbent assay 
(ELISA). Full blood count was estimated using Sysmex KX-21N haematology auto-analyzer.                      
Results: An overall prevalence of parvovirus B19 and P. falciparum co-infection observed among SCD 
patients in this study was 3.0% while single infection was 14.0% for P. falciparum and 26.7% for 
parvovirus B19. Religion was associated with 0 to 22 fold increased risk of acquiring co-infection of P. 
falciparum and parvovirus B19. Gender was significantly associated with P. falciparum infection 
(p=0.0291) while tribal extraction, platelet index and seasonal variation were significantly associated 
with single parvovirus B19 or co-infection of P. falciparum and parvovirus B19 (p<0.05).              
Conclusion: The provision of strict regulatory policy concerning the screening of whole blood or 
pooled plasma before the use of blood products and transfusion of SCD patients is advocated. 
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Abstrait: 
Contexte: Il a été largement rapporté que les infections par des parasites, des bactéries, des virus 
tels que le parvovirus humain B19, contribuent à la prévalence élevée de l'anémie dans de 
nombreuses populations. Cette étude visait à déterminer la co-infection de Plasmodium falciparum et 
du parvovirus humain B19 chez des patients atteints de drépanocytose à Benin City, dans l'État d'Edo, 
au Nigéria.    
Méthodologie: Un total de 400 participants comprenant 300 patients atteints de MCA (134 hommes, 
166 femmes) et 100 (38 hommes et 62 femmes) des sujets apparemment en bonne santé avec 
l'hémoglobine AA (qui servait de contrôle) qui ont été contactés à la maison, dans les écoles et au 
bureau inscrit à l'étude. L'âge des participants allait de 1 à 54 ans. Le sang veineux a été recueilli pour 
la détection de P. falciparum à l'aide de la coloration de Giemsa, tandis que le parvovirus B19 a été 
détecté par un test d'immunosorbant lié à une enzyme (ELISA). La numération globulaire totale a été 
estimée à l'aide de l'auto-analyseur d'hématologie Sysmex KX-21N. 
Résultats: La prévalence globale de la co-infection au parvovirus B19 et à P. falciparum observée 
chez les patients atteints de MCs dans cette étude était de 3,0%, tandis que l'infection simple était de 
14,0% pour P. falciparum et de 26,7% pour le parvovirus B19. La religion était associée à un risque 
accru de contracter la co-infection à P. falciparum et au parvovirus B19 de 0 à 22 fois plus élevé. Le 
sexe était significativement associé à l'infection à P. falciparum (p = 0,0291), tandis que l'extraction 
tribale, l'indice plaquettaire et la variation saisonnière étaient significativement associés à un 
parvovirus simple B19 ou à une co-infection à P. falciparum et au parvovirus B19 (p <0,05) 
Conclusion: La mise en place d'une politique réglementaire stricte concernant le dépistage du sang 
total ou du plasma réuni avant l'utilisation du produit sanguin et la transfusion de patients atteints de 
MCS est recommandée. 




 Sickle cell disease (SCD) is known 
to consist of several disorders 
characterized by the presence of sickle 
haemoglobin (1). An estimated 300,000 
children are born annually with SCD 
worldwide. This constitutes about 1% of 
the global population of SCD with over 
75% in sub-Saharan Africa (2, 3). The 
high birth rate of SCD has highlighted the 
burden of SCD as a public health priority 
(3). However, there is a dearth of 
information on the burden of SCD to 
healthcare system and the significance on 
individual health (4). 
       Infection with Parvovirus B19 is 
common and can lead to a variety of 
clinical manifestations based on the 
immunological and haematological status 
of patients (5). Parvovirus B19 belongs to 
the family Parvoviridae which is sub- 
divided into Parvovirinae and Densovirinae 
depending on the type of the infected host 
(6). Parvovirus B19 has specific tropism 
for erythroid progenitor cells and is 
capable of causing temporary infection of 
the bone marrow resulting in transient 
arrest of erythropoiesis (7). In patients 
with underlying haemolysis or haemato- 
logical disorders such as sickle cell 
disease, acute B19 infection may cause 
transient aplastic anaemia, erythema 
infectiosum, hydrops fetalis, abrupt and 
severe anaemia due to failure of red blood 
cell production (8, 9, 10). This virus is 
transmitted mainly via respiratory 
droplets but can be spread by 
contaminated blood, organ transplantation 
and transmission from mother to foetus 
(11).      
 Malaria is one of the major causes 
of morbidity and mortality in tropical and 
sub-tropical countries and is caused by 
the protozoan parasites of the genus 
Plasmodium with P. falciparum being the 
most virulent species (12). Malaria causes 
over 200 million cases of febrile illness out 
of which over a million children living in 
sub-Saharan Africa die annually (13, 14). 
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It is widely seen as a major health 
challenge in Africans with SCD (15).  
 Parvovirus B19 infection can cause 
significant drop in haemoglobin concen- 
tration and reticulocyte count, conditions 
that could have serious consequences in 
patients particularly children with under- 
lying malaria or those in malaria endemic 
regions (16). There are a number of 
studies that have emphasized the 
importance of co-infection with Parvovirus 
B19 in the etiology and pathogenesis of 
malaria in adults and children in non-
sickle cell disease subjects (17-22). It is 
recognized that interactions between SCD 
and other infectious agents influence the 
health status of SCD patients. Parasites, 
bacteria, human parvovirus B19, and 
other infectious agents have been widely 
reported as important factors contributing 
to the high prevalence of anaemia in 
many populations (23, 24, 25, 26). 
 There is however a dearth of 
information on the co-infection of P. 
falciparum and Parvovirus B19 among 
SCD patients in our environment. Against 
this background, this study was conducted 
to determine the co-infection of these 
pathogens among SCD patients in Benin 
City, Edo State, Nigeria. 
Materials and methods:  
Study population 
 The study was conducted between 
September 2017 and July 2018 at the 
Sickle Cell Center, Benin City, Edo State. 
The Sickle Cell Center has a referral status 
for the management of SCD patients Edo, 
Delta, and other neighbouring states. A 
total of 400 participants consisting of 300 
SCD patients (134 males and 166 
females) and 100 (38 males and 62 
females) apparently healthy subjects with 
haemoglobin AA that were contacted in 
homes, schools and offices (served as 
control), were enrolled for the study. The 
age of the participants ranged from 1 and 
54 years.     
 A well-structured questionnaire 
was administered to collect bio-data and 
other demographic information from the 
participants. Informed consent was 
obtained from all subjects or the parents 
or guardians in the case of children prior 
to specimen collection. The protocol for 
this study was approved by the Ethics and 
Research Committee of the Ministry of 
Health, Edo State, Nigeria. 
 
Specimen collection and processing 
 Venous blood sample of about 8 ml 
was collected from each participant, out of 
which 4.5 ml was dispensed into ethylene 
diamine tetraacetic acid (EDTA) bottle and 
thoroughly mixed. The remaining 3.5 ml 
sample was dispensed into plain 
container, allowed to clot, and serum 
separated for Parvovirus B19 analysis. 
Plasmodium falciparum was detected 
using a previously described method (27). 
Briefly, both thick and thin blood films 
were made from each blood specimen and 
allowed to air-dry. The blood films were 
stained in 3% Giemsa stain for 30 min, 
rinsed in tap water and allowed to air dry. 
The thick film was examined 
microscopically for presence of malaria 
parasite while the thin film was used to 
detect the species of Plasmodium using 
the oil immersion lens. A total of 200 
fields per film were examined. 
 Full blood count was analyzed 
using a Sysmex KX-21N haematology 
auto-analyzer (Sysmex Corporation, 
Japan). Whole blood specimen dispensed 
into EDTA container was used. Anaemia 
was defined using the WHO criteria as 
haemoglobin concentration <13 g/dl for 
males and <12 g/dl for females (28). 
Parvovirus B19 was detected using 
enzyme-linked immunosorbent assay 
(ELISA) technique (Serion classic 
Parvovirus B19 IgG/IgM Wuzburg, 
Germany). Briefly, each sample was 
assayed according to the manufacturer’s 
instruction using peroxidase-labeled rabbit 
anti-human IgM as the secondary 
antibody, tetramethyl benzidine as a 
substrate, and 1M H2SO4 as a stop 
solution. The absorbance was read at 450 
nm using a spectrophotometer. Index 
value between 10 and 15 was taken as 
reference value, with samples below the 
index range taken as negative while value 
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      The data generated were analyzed 
using Chi square (X2) test for frequency 
data whereas the odd ratio was calculated 
for each potential risk factor. The 
statistical software used was INSTAT 





 The prevalence of 26.7% for 
parvovirus B19, 14.0% for P. falciparum 
and 3.0% for co-infection of both 
pathogens were reported among the SCD 
patients, while prevalence of 4.7% for B19 
infection only was observed in the control 
subjects. Gender was not significantly 
associated with prevalence of B19 
infection or co-infection of B19 and P. 
falciparum (p>0.05) (Table 1). However, 
gender was significantly associated with 
the prevalence of P. falciparum infection 
among the SCD patients (OR=0.445; 95% 
CI=0.2186, 0.9095; p=0.0291). The age 
of SCD patients was not associated with 
single infection as well as co-infection of 
B19 and P. falciparum in the study 
(p>0.05). Educational status and religion 
were also not significantly associated with 
single and co-infection of B19 and P. 
falciparum (p>0.05).   
 Tribal extraction was significantly 
associated with single and co-infection of 
B19 and P. falciparum with the Etsako 
subjects (Edo State) being the most 
infected (53.9%) by B19 (p=0.0065), 
Yoruba tribe had the highest prevalence of 
P. falciparum infection (45.5%) 
(p=0.0137) while the Hausa tribe had the 
highest prevalence (20.0%) of coinfect- 
ion of B19 and P. falciparum among the 
SCD patients (p=0.0012). Seasonal 
variation was not significantly associated 
with prevalence of co-infection of B19 and 
P. falciparum (p>0.05). However, rainy 
season significantly influenced the 
prevalence of B19 infection among SCD 
patients (OR=2.077; 95% CI=1.171, 
3.684; p=0.0144)   
 
Table 1: Factors associated with infection of parvovirus B19 and Plasmodium falciparum among sickle cell disease 
patients in Benin-City, Nigeria 
 
Factors No tested No infected (%) OR 95%CI p value 
Gender  
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Table 2: Effect of haematological factors on co-infection of Parvovirus B19 and Plasmodium falciparum among 
Sickle Cell Disease patients in Benin-City, Nigeria 
 






























































































Platelet count (cells/μL) 
Parvovirus B19 
 < 150,000 
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 History of blood transfusion was 
not significantly associated with the 
prevalence of single or co-infection of B19 
and P. falciparum among the SCD patients 
(p>0.05) (Table 2). Anaemia was also not 
significantly associated with single or co-
infection of B19 and P. falciparum 
(p>0.05). However, platelets count was 
significantly associated with co-infection of 
B19 and P. falciparum among the SCD 
patients especially with platelet count              
of<150 cells/µL (OR 0.840, 95%CI 2.696, 




 Sickle cell disease runs a variable 
clinical course ranging from mild disease 
to severe life threatening complications 
(29). Individuals with SCD are known to 
be susceptible to infectious agents (30, 
31). This study examined parvovirus B19 
and P. falciparum infections in SCD 
patients in our locality. To our knowledge, 
this is the first study on this in Edo State. 
It has been hypothesized that depression 
of cell-mediated immunity in P. falciparum 
infection might favour co-infection with 
opportunistic pathogens including Parvo- 
virus B19 (32). An overall prevalence of 
parvovirus B19 and P. falciparum co-
infection observed in this study was 3.0% 
whereas the single infection was 14.0% 
for P. falciparum and 26.7% for B19. The 
prevalence of co-infection of B19 and P. 
falciparum observed in our study is lower 
than the 14.21% observed in non-SCD 
patients in Gabon (33). This difference in 
prevalence rates may be related to 
population studied, geographical location 
and seasonal variation. 
 Gender was not significantly 
associated with co-infection of P. 
falciparum and B19 although it was 
significantly associated with P. falciparum 
infection among the SCD patients. 
Similarly, age was not significantly 
associated with single infection or co-
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infection of B19 and P. falciparum among 
the SCD patients. These observations in 
our study may indicate adherence of SCD 
patients or their parents or guardians or 
relatives to health information that can aid 
quality of life of SCD patients, usually 
provided by their clinicians.  
 Patients or individuals living in 
malaria endemic regions are known to be 
at increased risk of serious complications 
with co-infection of B19 and P. falciparum 
(34). In individuals with SCD who have 
tolerated chronic anaemia, there could be 
rapid worsening of the anaemia, which 
can present as an emergency (4). Under 
these circumstances, anaemia becomes 
life threatening and requires prompt 
treatment with blood transfusion to 
reduce the deleterious effects of 
haemoglobin S and improve outcome (4). 
Parvovirus B19 and P. falciparum are 
easily transmitted by blood transfusion 
and transfusion with plasma derived 
products (35). SCD patients are known to 
be at high risk of transfusion-transmissible 
infections since they receive frequent, 
often unplanned, emergency blood 
transfusion (36, 37). Surprisingly, history 
of blood transfusion was not significantly 
associated with single and co-infection of 
B19 and P. falciparum among our SCD 
patients. The reason for this finding is 
unclear. 
 In this study, religion and 
educational status of our SCD patients 
were not significantly associated with 
single or co-infection of B19 and P. 
falciparum. However, tribal extraction was 
significantly associated with single or co-
infection of B19 and P. falciparum among 
the SCD patients, with the SCD patients of 
Etsako tribe in Edo State having the 
highest prevalence (53.9%) of B19 
infection, the Yoruba tribe had the highest 
prevalence (45.5%) of P. falciparum while 
the Hausa tribe had the highest 
prevalence of co-infection (20.0%) of B19 
and P. falciparum. The reasons for these 
tribal differences remain to be elucidated. 
Seasonal variation in prevalence of 
malaria is well established with highest 
prevalence during the rainy season (38, 
39). Surprisingly, seasonal variation was 
not significantly associated with pre- 
valence of P. falciparum malaria and co-
infection of B19 and P. falciparum in our 
SCD patients, but was significantly 
associated with the prevalence of B19 
infection, with highest prevalence (31.6%) 
in the raining season compared to the dry 
season (18.2%) (p=0.0144).  
 Both immunological and non-
immunological destructions of platelets 
have been implicated to cause 
thrombocytopenia, resulting from consum- 
ptive coagulopathy, platelet sequestration 
in spleen, antibody mediated platelet 
destruction and oxidative stress. Platelet 
may also act as cofactor to trigger severe 
malaria, and abnormalities in platelet 
structure and function have been 
described as a consequence of malaria 
and in rare instances, platelets can be 
invaded by malaria parasites (40, 41, 42). 
Previous studies have indicated the 
involvement of white cells and platelets in 
single infection and co-infection of B19 
and P. falciparum (43, 44, 45, 46). In our 
study, platelet index was not significantly 
associated with prevalence of single 
infection of B19 or P. falciparum. 
However, platelet count of <150 cells/µL 
was a risk factor as it was associated with 
a 2 to 43 fold increased risk of acquiring 
co-infection of B19 and P. falciparum 
among our SCD patients. In addition, 
platelet index was significantly associated 
with the prevalence of co-infection of B19 
and P. falciparum among the SCD 
patients. Our findings are in agreement 
with the previous report of Girei et al. 
among SCD patients with B19 infection in 
Jos (46). 
 Parvovirus B19 and P. falciparum 
co-infections have been reported to cause 
severe anaemia, which can be fatal 
particularly among SCD patients (11, 47, 
48). Parvovirus B19 causes anaemia 
because it selectively inhibits and lyse 
actively replicating erythroid progenitor 
cells (9, 49) which are targets of P. 
falciparum, co-infection of the two 
pathogens therefore result in severe 
anaemia (19, 50, 51). Surprisingly, 
anaemia was not significantly associated 
with single infection or co-infection of 
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parvovirus B19 and P. falciparum among 
our SCD patients. Our finding is consistent 
with the previous study of Toan et al. (33) 
who also did not observe significant 
difference in haemoglobin concentration 
among non-SCD patients with co-
infections of B19 and P. falciparum. The 




 An overall prevalence of parvovirus 
B19 and P. falciparum co-infection of 
3.0% was observed in our SCD patients in 
this study, and single infection of 14.0% 
for P. falciparum and 26.7% for B19 were 
similarly reported. While gender was 
significantly associated with P. falciparum 
infection among our SCD patients, tribal 
extraction, platelet index and seasonal 
variation were significantly associated with 
single parvovirus B19 infection or              
co-infection of B19 and P. falciparum. The 
provision of strict regulatory policy 
concerning the screening of whole blood 
or pooled plasma before transfusion of 
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